Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Liver Cirrhosis

Free Subscription 02.10.2023 2 BMC Gastroenterol 1 Dig Dis Sci 3 Gastroenterology 4 Hepatology 1 PLoS One 1 Transplant Proc

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Gastroenterol

1. YAN W, Yao Z, Ou Q, Ye G, et al
   Establishment and validation of a prognosis nomogram for MIMIC-III patients with liver cirrhosis complicated with hepatic encephalopathy.
   BMC Gastroenterol. 2023;23:335.
   PubMed         Abstract available
   
   
2. ZHOU H, Wu M, Yu S, Xia H, et al
   Comparison of the efficacy and safety between rivaroxaban and dabigatran in the treatment of acute portal vein thrombosis in cirrhosis.
   BMC Gastroenterol. 2023;23:329.
   PubMed         Abstract available
   
   

   
   Dig Dis Sci

3. LI R, Li M, Bidulescu A, Fly AD, et al
   Diets with Higher Anti-inflammatory Potential Associated with Lower Risk of Development of Nonalcoholic Fatty Liver Disease and Early-Stage of Fibrosis Among US Adults.
   Dig Dis Sci. 2023;68:4009-4021.
   PubMed         Abstract available
   
   

   
   Gastroenterology

4. AMPUERO J, Berzigotti A
   Prognostication in Advanced Chronic Liver Disease Using Liver Stiffness Measurement: Repetita Iuvant.
   Gastroenterology. 2023;165:829-831.
   PubMed        
   
   
5. SEMMLER G, Yang Z, Fritz L, Kock F, et al
   Dynamics in Liver Stiffness Measurements Predict Outcomes in Advanced Chronic Liver Disease.
   Gastroenterology. 2023;165:1041-1052.
   PubMed         Abstract available
   
   
6. MAN S, Deng Y, Ma Y, Fu J, et al
   Prevalence of Liver Steatosis and Fibrosis in the General Population and Various High-Risk Populations: A Nationwide Study With 5.7 Million Adults in China.
   Gastroenterology. 2023;165:1025-1040.
   PubMed         Abstract available
   
   

   
   Hepatology

7. CHEN W, Sun Y, Chen S, Ge X, et al
   Matrisome gene-based subclassification of patients with liver fibrosis identifies clinical and molecular heterogeneities.
   Hepatology. 2023;78:1118-1132.
   PubMed         Abstract available
   
   
8. LI J, Lu X, Zhu Z, Kalutkiewicz KJ, et al
   Head-to-head comparison of magnetic resonance elastography-based liver stiffness, fat fraction, and T1 relaxation time in identifying at-risk NASH.
   Hepatology. 2023;78:1200-1208.
   PubMed         Abstract available
   
   
9. MINCIUNA I, Gallage S, Heikenwalder M, Zelber-Sagi S, et al
   Intermittent fasting-the future treatment in NASH patients?
   Hepatology. 2023;78:1290-1305.
   PubMed         Abstract available
   
   
10. CALZADILLA-BERTOT L, Jeffrey GP, Wang Z, Huang Y, et al
    Predicting liver-related events in NAFLD: A predictive model.
    Hepatology. 2023;78:1240-1251.
    PubMed         Abstract available
    
    

    
    PLoS One

11. YOSHIDA Y, Atsukawa M, Kondo C, Kitamura M, et al
    A novel formula used for predicting hepatocellular carcinoma after the achievement of sustained virologic response by direct-acting antivirals in patients with chronic hepatitis C.
    PLoS One. 2023;18:e0292019.
    PubMed         Abstract available
    
    

    
    Transplant Proc

12. BEZINOVER D, Alhkouri N, Schumann R, Geyer N, et al
    Liver Transplant Outcomes in Young Adults with Cirrhosis Related to Nonalcoholic Fatty Liver Disease.
    Transplant Proc. 2023 Sep 24:S0041-1345(23)00561.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Cirrhosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: